The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net income | 6,288 | 3,778 | 5,372 | 6,746 |
| Depreciation and amortization | 2,775 | 2,775 | 3,035 | 2,937 |
| Realized investment losses (gains), net | - | - | -78 | -495 |
| Investment losses, net | -24 | -2,737 | - | - |
| Deferred income tax expense (benefit) | -326 | 95 | 1,659 | 480 |
| Net (gain) loss on sale of businesses | 13 | 24 | -1,499 | 1,662 |
| Debt extinguishment costs | - | - | 0 | 0 |
| Accounts receivable, net | 4,630 | 7,369 | 1,663 | 2,237 |
| Inventories | 646 | 1,032 | 868 | 1,055 |
| Reinsurance recoverable and other assets | 897 | 485 | 539 | 38 |
| Insurance liabilities | 1,247 | -591 | 584 | 291 |
| Pharmacy and other service costs payable | 1,868 | 8,757 | 2,030 | 1,760 |
| Accounts payable and accrued expenses and other liabilities | 2,797 | 1,138 | 3,481 | 1,574 |
| Other, net | -462 | -774 | -463 | -325 |
| Net cash provided by operating activities | 9,601 | 10,363 | 11,813 | 8,656 |
| Debt securities and equity securities | 782 | 856 | 1,078 | 1,744 |
| Debt securities and equity securities | 986 | 839 | 972 | 1,327 |
| Commercial mortgage loans | 223 | 188 | 186 | 98 |
| Other sales, maturities and repayments (primarily short-term and other long-term investments) | 884 | 752 | 586 | 1,039 |
| Debt securities and equity securities | 5,788 | 1,386 | 4,334 | 2,756 |
| Commercial mortgage loans | 117 | 54 | 118 | 161 |
| Other (primarily short-term and other long-term investments) | 1,416 | 1,309 | 1,205 | 1,563 |
| Property and equipment purchases, net | 1,212 | 1,406 | 1,573 | 1,295 |
| Acquisitions, net of cash acquired | 597 | 131 | 447 | 0 |
| Divestitures, net of cash sold | 2,984 | 521 | 13 | 4,835 |
| Renewable energy tax credit equity investments | 1,102 | 1,030 | - | - |
| Other, net | 34 | -58 | 332 | 170 |
| Net cash used in investing activities | -4,407 | -2,102 | -5,174 | 3,098 |
| Deposits and interest credited to contractholder deposit funds | 152 | 166 | 167 | 164 |
| Withdrawals and benefit payments from contractholder deposit funds | 253 | 228 | 223 | 220 |
| Net change in short-term debt, excluding term loan | -927 | -402 | 1,198 | -2,059 |
| Net proceeds on issuance of term loan | 1,999 | - | - | 0 |
| Repayment of term loan | 2,000 | - | - | 0 |
| Payments for debt extinguishment | - | - | 0 | 0 |
| Repayment of long-term debt | 4,197 | 3,000 | 2,967 | 500 |
| Net proceeds on issuance of long-term debt | 4,458 | 4,462 | 1,491 | 0 |
| Repurchase of common stock | 3,621 | 7,034 | 2,284 | 7,607 |
| Issuance of common stock | 203 | 305 | 187 | 389 |
| Common stock dividend paid | 1,611 | 1,567 | 1,450 | 1,384 |
| Other, net | -624 | -349 | -413 | -23 |
| Net cash used in financing activities | -6,421 | -7,647 | -4,294 | -11,240 |
| Effect of foreign currency rate changes on cash, cash equivalents and restricted cash | 32 | -20 | 16 | -86 |
| Net (decrease) increase in cash, cash equivalents and restricted cash | -1,195 | 594 | 2,361 | 428 |
| Cash, cash equivalents and restricted cash january 1, including held for sale assets | 8,931 | 8,337 | 5,976 | - |
| Cash, cash equivalents and restricted cash december 31, including held for sale assets | 7,736 | 8,931 | 8,337 | 5,548 |
| Cash and cash equivalents reclassified to assets of businesses held for sale | 0 | - | - | - |
| Cash, cash equivalents and restricted cash and cash equivalents december 31, | 7,736 | - | - | 5,976 |
Cigna Group (CI)
Cigna Group (CI)